Beth Helmink

Medicine & Life Sciences

1. 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione 25%
2. Allergy and Immunology 16%
3. Antigen Receptors 57%
4. Ataxia Telangiectasia 41%
5. B-Lymphocytes 28%
6. B-Lymphoid Precursor Cells 24%
7. Cell Division 14%
8. Cell- and Tissue-Based Therapy 14%
9. Chromatin 30%
10. Chromosome Breakage 20%
11. Colitis 32%
12. Continuity of Patient Care 18%
13. Cytidine Diphosphate Choline 18%
14. Cytidine Triphosphate 43%
15. Dietary Fiber 18%
16. DNA 47%
17. DNA Breaks 18%
18. DNA Cleavage 17%
19. DNA Damage 46%
20. Double-Stranded DNA Breaks 100%
21. Drosophila melanogaster 17%
22. Endonucleases 31%
23. Fecal Microbiota Transplantation 45%
24. G1 Phase 50%
25. Gastrointestinal Microbiome 53%
26. Genes 23%
27. Glioblastoma 15%
28. Hematopoietic Stem Cells 15%
29. Histones 21%
30. Immunity 18%
31. Immunotherapy 48%
32. Infant Nutrition Disorders 26%
33. Leprosy 17%
34. Ligases 17%
35. Lymphocytes 65%
36. Lysine 15%
37. Manuscripts 18%
38. Medicine 15%
39. Melanoma 41%
40. Microbiota 65%
41. Neoplasms 62%
42. Omentum 19%
43. Peritoneal Macrophages 17%
44. Phosphatidylcholines 19%
45. Phosphorylcholine 40%
46. Probiotics 16%
47. Tertiary Lymphoid Structures 26%
48. Therapeutics 25%
49. Ubiquitin 15%
50. V(D)J Recombination 71%